OpGen > News > OpGen Announces Strategic Collaboration with IQT to Develop High-Throughput Genomic Assembly and Analysis System

OpGen Announces Strategic Collaboration with IQT to Develop High-Throughput Genomic Assembly and Analysis System

 

Media Contact:
Dan Budwick 
Pure Communications, Inc.
(973) 271-6085 

Opgen Contact:
Judy Macemon 
VP Marketing, Opgen, Inc.
(240) 813-1279 

 

OpGen Announces Strategic Collaboration with IQT to Develop High-Throughput Genomic Assembly and Analysis System

Gaithersburg, Md.—May 1, 2012— OpGen, Inc., a commercial stage whole-genome analysis company, today announced a strategic collaboration with In-Q-Tel (IQT), the non-profit, strategic investment firm that delivers innovative technology solutions to support the missions of the U.S. Intelligence Community. The collaboration is focused on developing a new high- throughput sequence and genome mapping pipeline for microbial genome analysis. The technology is being developed for the Department of Homeland Security Science and Technology Directorate (DHS S&T), an IQT customer agency, and the National Bioforensic Analysis Center, a DHS S&T laboratory. 

“OpGen is the leader in developing Whole Genome Mapping technologies for use with next generation sequencing (NGS) analysis pipelines,” said Simon Davidson, partner on IQT’s Investments team. “The company is the ideal partner to develop new software for high performance microbial data analysis to increase the speed and accuracy of analyzing samples from different sources to detect potential bio-threat organisms that may pose a danger to public health.” 

The enhanced application will automate the generation of OpGen’s Whole Genome Maps for use in high-throughput genomic assembly and analysis pipelines. The suite of applications in the pipeline will automatically align DNA sequence data to a map of the entire genome and recommend the most accurate finished sequences derived from the highest confidence alignments. The software system is being developed for use with computer clusters and cloud computing to provide rapid, accurate, reproducible and standardized assembly of microbial genome sequences.

 “Combining OpGen’s Whole Genome Maps with next-generation sequencing saves finishing cost and time while significantly increasing accuracy,” said Richard Moore, M.D., Ph.D., chief scientific officer of OpGen. “The additional automation to be provided by this collaboration will make the finishing process much more efficient. In addition, this project will enable more flexible configuration of the Argus® system allowing us to better meet the analysis needs of our customers.” 

“We are pleased to partner with IQT to develop innovative tools for high-throughput, whole genome, sequence analysis,” said Douglas White, chief executive officer of OpGen. “Our ultimate goal is to develop systems, databases and services that simplify and standardize processes and information to enable the broader adoption of next-generation sequencing and Whole Genome Mapping for practical application in the biodefense, public health and clinical markets.” 

About OpGen, Inc.

OpGen, Inc. is a leading innovator in providing rapid, accurate genomic and DNA analysis systems and services. The company’s Argus® Whole Genome Mapping System, GenomeBuilder™ and MapIt® Services provide high resolution, whole genome maps for sequence assembly and finishing, strain typing and comparative genomics in the life sciences market. OpGen’s powerful technology dramatically improves the quality of data and time-to results by providing sequence information from single DNA molecules more rapidly and less expensively than previously possible. The company is dedicated to positively influencing individual healthcare outcomes, advancing scientific research and enhancing public health by delivering precise, actionable information and results to customers in the life science and healthcare communities. OpGen’s customers include leading genomic research centers, biodefense organizations, academic institutions, clinical research organizations and biotechnology companies. For more information, visit www.opgen.com.

 About IQT

In-Q-Tel is the not-for-profit, strategic investment firm that works to identify, adapt, and deliver innovative technology solutions to support the missions of the U.S. Intelligence Community. Launched in 1999 as a private, independent organization, IQT’s mission is to identify and partner with companies developing cutting-edge technologies that serve the national security interests of the United States. Working from an evolving strategic blueprint defining the Intelligence Community’s critical technology needs, IQT engages with entrepreneurs, startups, researchers, and investors to deliver technologies that provide superior capabilities for the CIA and broader Intelligence Community. For more information, visit www.iqt.org.

← go back